Notifications
- 2020.10.19Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2019 Statement)
- 2020.02.14Summit Pharmaceuticals International Corporation Invests in Luxna Biotech Co., Ltd. Possessing the Nucleic Acid Pharmaceutical Element Technologies
- 2019.10.25Signed a Contract for Sale of Stem Cells from Human Exfoliated Deciduous Teeth between Gene Techno Science Co., Ltd. and Summit Pharmaceuticals International Corporation.
- 2019.10.07Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2018 Statement)
- 2019.10.01Establishment of a new cosmetics company
- 2019.03.14CytoReason and Summit Pharmaceuticals International Forge Commercial Alliance To Bring CytoReason’s Machine Learning Model of the Immune System for Drug Discovery & Development To Japanese Drug Makers
- 2019.02.05We will set up a booth at CPhI Japan 2019
- 2018.09.28Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2017 Statement)
- 2017.10.11Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2016 Statement)
- 2017.05.01Our head office in Tokyo will move as of May 22, 2017
- 2017.02.21We will set up a booth at CPhI Japan 2017
- 2016.06.14Successful Identification of Metabolite Differences in Urine between Healthy, Breast Cancer and Colorectal Cancer Groups
CONTACT
(10:00 to 17:00, weekdays only)